Suggested remit: To appraise the clinical and cost effectiveness of 3D collagen matrix (novocart 3D) within its marketing authorisation for treating articular cartilage defects of the knee.
Status Proposed
Process STA 2018
ID number 2707

Project Team

Project lead Michelle Adhemar

Email enquiries


Key events during the development of the guidance:

Date Update
15 June 2020 - 13 July 2020 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance